Ithaar Derweesh
About
Ithaar Derweesh is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology.
According to data from OpenAlex, Ithaar Derweesh has authored 249 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 195 papers in Pulmonary and Respiratory Medicine, 94 papers in Surgery and 85 papers in Molecular Biology. Recurrent topics in Ithaar Derweesh's work include Renal cell carcinoma treatment (159 papers), Renal and related cancers (80 papers) and Bladder and Urothelial Cancer Treatments (50 papers). Ithaar Derweesh is often cited by papers focused on Renal cell carcinoma treatment (159 papers), Renal and related cancers (80 papers) and Bladder and Urothelial Cancer Treatments (50 papers). Ithaar Derweesh collaborates with scholars based in United States, Italy and Japan. Ithaar Derweesh's co-authors include Steven C. Campbell, Andrew C. Novick, Robert G. Uzzo, Jihad Kaouk, Brian R. Lane, Surena F. Matin, George K. Chow, Martha M. Faraday, Michael L. Blute and Arie S. Belldegrun and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.
In The Last Decade
Ithaar Derweesh
227 papers receiving 7.0k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ithaar Derweesh United States | 41 | 5.7k | 3.6k | 2.4k | 881 | 803 | 249 | 7.1k | ||
| Marc C. Smaldone United States | 40 | 3.8k 0.7× | 1.8k 0.5× | 1.7k 0.7× | 602 0.7× | 557 0.7× | 234 | 5.3k | ||
| Luca Cindolo Italy | 44 | 5.1k 0.9× | 3.0k 0.8× | 2.2k 0.9× | 950 1.1× | 437 0.5× | 229 | 6.9k | ||
| Francis J. McGovern United States | 29 | 4.4k 0.8× | 2.6k 0.7× | 1.4k 0.6× | 1.6k 1.8× | 1.0k 1.3× | 90 | 6.5k | ||
| Alessandro Antonelli Italy | 36 | 2.7k 0.5× | 1.4k 0.4× | 1.8k 0.7× | 524 0.6× | 245 0.3× | 411 | 5.0k | ||
| Jianbo Li United States | 35 | 2.4k 0.4× | 772 0.2× | 1.0k 0.4× | 300 0.3× | 435 0.5× | 187 | 4.5k | ||
| Pasquale Ditonno Italy | 43 | 2.0k 0.3× | 1.7k 0.5× | 951 0.4× | 591 0.7× | 117 0.1× | 152 | 4.5k | ||
| Iris Baumgärtner Switzerland | 49 | 3.9k 0.7× | 2.1k 0.6× | 6.7k 2.8× | 460 0.5× | 385 0.5× | 323 | 11.0k | ||
| Jeffrey M. Slezak United States | 40 | 3.2k 0.6× | 592 0.2× | 1.2k 0.5× | 595 0.7× | 216 0.3× | 99 | 5.2k | ||
| Rolf M.F. Berger Netherlands | 49 | 6.0k 1.1× | 1.0k 0.3× | 1.4k 0.6× | 189 0.2× | 361 0.4× | 235 | 8.2k | ||
| Richard Cowan United Kingdom | 40 | 2.4k 0.4× | 743 0.2× | 1.0k 0.4× | 1.0k 1.2× | 776 1.0× | 138 | 5.2k |
Countries citing papers authored by Ithaar Derweesh
Since
Specialization
Citations
This map shows the geographic impact of Ithaar Derweesh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ithaar Derweesh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ithaar Derweesh more than expected).
Fields of papers citing papers by Ithaar Derweesh
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ithaar Derweesh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ithaar Derweesh. The network helps show where Ithaar Derweesh may publish in the future.
Co-authorship network of co-authors of Ithaar Derweesh
This figure shows the co-authorship network connecting the top 25 collaborators of Ithaar Derweesh. A scholar is included among the top collaborators of Ithaar Derweesh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ithaar Derweesh. Ithaar Derweesh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Chen, Wei, Hajime Tanaka, Masaki Kobayashi, et al.. (2025). Racial disparity in preoperative C‐reactive protein level for predicting prognosis of patients with non‐metastatic clear cell renal cell carcinoma: INMARC study. International Journal of Urology. 32(4). 414–422.
2.
Chen, Wei, Hajime Tanaka, Masaki Kobayashi, et al.. (2025). Development and validation of nomograms and integrated software incorporating preoperative C-reactive protein level for prognostic prediction of nonmetastatic clear cell renal cell carcinoma: Results from the International Marker Consortium for Renal Cancer (INMARC) Registry. World Journal of Urology. 43(1). 63–63.
3.
Hakimi, Kevin, Margaret Meagher, Franklin Liu, et al.. (2024). SHIFTING THE PARADIGM: THE INTRIGUING ROLE OF C-REACTIVE PROTEIN IN RENAL CELL CARCINOMA STAGING WITHIN THE AJCC SYSTEM -ANALYSIS OF THE INMARC REGISTRY. Urologic Oncology Seminars and Original Investigations. 42. S41–S41.
4.
Hakimi, Kevin, Margaret Meagher, Franklin Liu, et al.. (2024). C-REACTIVE PROTEIN KINETICS ARE ASSOCIATED WITH PROGRESSION AND SURVIVAL IN SURGICALLY TREATED RENAL CELL CARCINOMA PATIENTS. Urologic Oncology Seminars and Original Investigations. 42. S65–S65.
5.
Noyes, Sabrina L., Margaret Meagher, Richard K.K. Yuen, et al.. (2024). MP51-08 EXTERNAL VALIDATION OF RENSAFE: A TOOL TO PREDICT ACUTE KIDNEY INJURY AND CHRONIC KIDNEY DISEASE >3B POST PARTIAL OR RADICAL NEPHRECTOMY. The Journal of Urology. 211(5S).
6.
Pan, Elizabeth, Andrew Elliott, Shankar Siva, et al.. (2024). Characterization of FOLH1 Expression in Renal Cell Carcinoma. Cancers. 16(10). 1855–1855.
7.
Bagrodia, Aditya, et al.. (2024). Oncological and Survival Outcomes of Pelvic Lymph Node Dissection in Patients with Nonmuscle Invasive Bladder Cancer Undergoing Radical Cystectomy Using the National Cancer Database. Clinical Genitourinary Cancer. 22(6). 102197–102197.
8.
Shabaik, Ahmed, Ithaar Derweesh, Aditya Bagrodia, et al.. (2023). Outcomes of Patients With Advanced Renal Cell Carcinoma With Non-Clear Cell Histology Treated With Systemic Therapy. Clinical Genitourinary Cancer. 21(6). 660–668.e1.
9.
Murphy, James D., et al.. (2023). Comparison of Capture Rates of the National Cancer Database Across Race and Ethnicity. JAMA Network Open. 6(12). e2350237–e2350237.
10.
Pandolfo, Savio Domenico, Davide Loizzo, Alp Tuna Beksaç, et al.. (2022). Percutaneous thermal ablation for cT1 renal mass in solitary kidney: A multicenter trifecta comparative analysis versus robot-assisted partial nephrectomy. European Journal of Surgical Oncology. 49(2). 486–490.
11.
Saito, Kazutaka, Yosuke Yasuda, Hajime Tanaka, et al.. (2022). Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort. Clinical Genitourinary Cancer. 20(4). e276–e282.
12.
Pandolfo, Savio Domenico, Alp Tuna Beksaç, Ithaar Derweesh, et al.. (2022). Percutaneous Ablation vs Robot-Assisted Partial Nephrectomy for Completely Endophytic Renal Masses: A Multicenter Trifecta Analysis with a Minimum 3-Year Follow-Up. Journal of Endourology. 37(3). 279–285.
13.
Shaya, Justin, et al.. (2021). Prognostic Significance of Pancreatic Metastases in Patients With Advanced Renal Cell Carcinoma Treated With Systemic Therapy. Clinical Genitourinary Cancer. 19(6). e367–e373.
14.
Lin, Xun, et al.. (2020). The Impact of Age and Gender on Outcomes of Patients With Advanced Renal Cell Carcinoma Treated With Targeted Therapy. Clinical Genitourinary Cancer. 18(5). e598–e609.
15.
Bergerot, Cristiane Decat, Dena Battle, Errol J. Philip, et al.. (2020). Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma. JCO Oncology Practice. 16(11). e1264–e1271.
16.
Bindayı, Ahmet, Michelle McDonald, Alp Tuna Beksaç, et al.. (2018). Can multiphase CT scan distinguish between papillary renal cell carcinoma type 1 and type 2?. SHILAP Revista de lepidopterología. 44(4). 316–322.
17.
Fero, Katherine E., Zachary Hamilton, Ahmet Bindayı, James D. Murphy, & Ithaar Derweesh. (2017). Utilization and quality outcomes of cT 1a, cT 1b and cT 2a partial nephrectomy: analysis of the national cancer database. British Journal of Urology. 121(4). 565–574.
18.
Patel, Nishant, Jason Woo, Michael A. Liss, et al.. (2016). Does timing of targeted therapy for metastatic renal cell carcinoma impact treatment toxicity and surgical complications? A comparison of primary and adjuvant approaches.. PubMed. 23(2). 8227–33.
19.
Kopp, Ryan, et al.. (2012). Initial Experience with Aspirin Use During Robotic Radical Prostatectomy. Journal of Laparoendoscopic & Advanced Surgical Techniques. 22(3). 225–229.
20.
Kudo, Daisuke, Patricia Rayman, Luis Moltó, et al.. (2004). Degradation of NF-κB in T Cells by Gangliosides Expressed on Renal Cell Carcinomas. The Journal of Immunology. 172(6). 3480–3490.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Marc C. Smaldone Breakdown of academic impact, for papers by Luca Cindolo Breakdown of academic impact, for papers by Francis J. McGovern Breakdown of academic impact, for papers by Alessandro Antonelli Breakdown of academic impact, for papers by Jianbo Li Breakdown of academic impact, for papers by Pasquale Ditonno Breakdown of academic impact, for papers by Iris Baumgärtner Breakdown of academic impact, for papers by Jeffrey M. Slezak Breakdown of academic impact, for papers by Rolf M.F. Berger Breakdown of academic impact, for papers by Richard Cowan